SLS - SELLAS Life Sciences GAAP EPS of -$0.47 misses by $0.18 May, 11 2023 05:05 PM SELLAS Life Sciences Group Inc. 2023-05-11 17:05:31 ET SELLAS Life Sciences press release ( NASDAQ: SLS ): Q1 GAAP EPS of -$0.47 misses by $0.18 . As of March 31, 2023, cash and cash equivalents totaled approximately $23.9 million. For further details see: SELLAS Life Sciences GAAP EPS of -$0.47 misses by $0.18